Blog

Investors in PTC Inc. PTC need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $230.00 Call had some of the highest implied

Zacks Investment Research has recently initiated coverage of Fusemachines Inc. FUSE with an Underperform recommendation, citing a combination of financial, operational, and competitive challenges

Acuity Inc. AYI shows how an established lighting company can become a broader industrial technology story. Demand is increasingly tied to intelligent buildings, connected controls and data-enabled

Analog Devices ADI has a strong cash flow profile supported by high gross margins, low capital intensity and disciplined capital allocation. During the first six months of fiscal 2026, the company

AbbVie ABBV announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending approval for its blockbuster

Investors in ResMed Inc. RMD need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $200.00 Call had some of the highest implied

Spyre Therapeutics SYRE has given investors a classic biotech dilemma. The pipeline is advancing, the cash balance is large and the stock has already moved sharply higher.

That also makes the

Alto Ingredients, Inc. ALTO is increasingly looking beyond ethanol and positioning carbon dioxide (CO2) as a higher-value growth opportunity that could strengthen its earnings mix over time. In its

Acuity Inc. AYI has given investors a stronger operating story after its fiscal third-quarter results, but that does not automatically make the stock a clear buy.The company has earnings support

Growing investment in mission-critical infrastructure, advanced manufacturing, power systems and data center development continues to create attractive opportunities across the engineering and

Arm Holdings ARM is stepping up its ambitions in AI infrastructure with the Arm AGI CPU, a processor purpose-built for the emerging era of agentic AI workloads. The company believes the shift from

The TJX Companies, Inc.’s TJX HomeGoods banner is increasingly looking like more than just a complementary business within the retailer's portfolio. The chain is emerging as a meaningful earnings

Spyre Therapeutics SYRE gives investors a focused view of how inflammatory bowel disease drug development is changing.

The company is not built around a single asset. It is pursuing long-acting

Investors in Verisk Analytics, Inc. VRSK need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 18, 2026 $140.00 Call had some of the highest

Spyre Therapeutics SYRE has become a closely watched clinical-stage biotech stock as investors look ahead to a busy stretch of data readouts that could define the company’s next phase. The company

Acadia Pharmaceuticals ACAD shares climbed 6.8% on Friday after the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion following a

Acuity Inc. AYI is no longer just a lighting story. The company is increasingly defined by its move into intelligent buildings, software-enabled controls and audio-visual platforms.

That shift is

Shares of Assurant, Inc. AIZ closed at $264.43 on Friday, near its 52-week high of $268.67. This proximity underscores investor confidence. It has the ingredients for further price appreciation. The

On Friday, stocks of four large drugmakers, Eli Lilly LLY, AbbVie ABBV, J&J JNJ and Biogen BIIB hit fresh 52-week highs. However, the rally in the four stocks was not driven by a single catalyst

Novo Nordisk NVO and Viking Therapeutics VKTX are both riding on the powerful growth trend in obesity care, a market expected to expand significantly as demand for effective weight-loss treatments

Fortinet's FTNT push to expand its FortiGate hardware lineup and cloud-delivered security operations platform is reigniting investor attention on the cybersecurity firm's growth runway. The company

Investors in Ardent Health, Inc. ARDT need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 15, 2027 $2.50 Call had some of the highest

Microchip Technology MCHP has introduced the DSA504RT, a space-grade, radiation-tolerant programmable clock generator with six outputs, developed to meet the demanding timing requirements of

We begin a new holiday-shortened trading week (we’ll observe Independence Day this year on Friday, July 3rd, which will make for a nice three-day weekend) looking at jobs numbers from last week

For Immediate Release

Chicago, IL – June 29, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and